Emer­gent, HHS dis­close $250M up­dat­ed con­tract that in­cludes an­thrax and small­pox vac­cines

Emer­gent BioSo­lu­tions scored more than $250 mil­lion in gov­ern­ment con­tract mod­i­fi­ca­tions for four med­ical coun­ter­mea­sures, in­clud­ing an­thrax, small­pox and bot­u­lism vac­cines.

As part of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.